Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Na Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-1677-6159; OpenAlex author ID A5101764433. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 4

  1. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Co-author DOI 10.1016/j.ejphar.2024.176357↗
  2. Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway. Co-author DOI 10.1016/j.jprot.2024.105182↗
  3. Circular RNA hsa_circ_0001846 facilitates the malignant behaviors of pancreatic cancer by sponging miR-204-3p and upregulating KRAS expression. Co-author DOI 10.1038/s41420-023-01733-2↗
  4. Circular RNA hsa_circ_0007367 promotes the progression of pancreatic ductal adenocarcinoma by sponging miR-6820-3p and upregulating YAP1 expression. Co-author DOI 10.1038/s41419-022-05188-8↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haijun Wang · 2 shared papers, 2024 · strength 0.45
  2. Haocheng Zhang · 2 shared papers, 2022–2023 · strength 0.28
  3. Xinyu Li · 2 shared papers, 2022–2023 · strength 0.28
  4. Xiaolei Ma · 2 shared papers, 2022–2023 · strength 0.28
  5. Guofen Qiao · 2 shared papers, 2022–2023 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.